Jessica Hopfield Editas Medicine, Inc. (EDIT) insider trading activity
Jessica Hopfield is Director of Editas Medicine, Inc.. Currently has a direct ownership of 67,700 shares of EDIT, which is worth approximately $81,917. The most recent transaction as insider was on May 13, 2024, when has been sold 45,000 shares (Common Stock) at a price of $5.64 per share, resulting in proceeds of $253,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
67.7K
0%
3M change
198.24%
12M change
Total Value Held
$81,917
Jessica Hopfield Transaction History
Also insider at
JH
Jessica Hopfield
Director
Emeryville, CA